ELISA Kit for Fibronectin Type III Domain Containing Protein 5 (FNDC5)
SEN576HU
Product group Assays
Overview
- SupplierCloud-Clone Corp.
- Product NameELISA Kit for Fibronectin Type III Domain Containing Protein 5 (FNDC5)
- Delivery Days Customer12
- Assay Detection Range15.6-1,000pg/mL
- Assay PrecisionIntra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Fibronectin Type III Domain Containing Protein 5 (FNDC5) were tested 20 times on one plate, respectively. Inter-assay Precision (Precision between assays): ...
- Assay SensitivityThe minimum detectable dose of this kit is typically less than 6.9pg/mL
- Assay Test PrincipleThe test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Fibronectin Type III Domain Containing Protein 5 (FNDC5). Standards or samples are then ...
- Assay Time3h
- CertificationResearch Use Only
- UNSPSC41116158
References
- Balcázar-Hernandez L, Basurto L, Manuel-Apolinar L, et al. Pattern of Adiponectin, Osteocalcin, Irisin, FGF-21, and MCP-1 According to the Body Size Phenotype: Could They Be Markers of Metabolic Health in Mexican-Mestizo Middle-Aged Women? Metabolites. 2021,11(11). doi: 10.3390/metabo11110771Read this paper
- Altay DU, Korkmaz M, Ergun S, et al. Salivary irisin: potential inflammatory biomarker in recurrent apthous stomatitis patients. Eur Rev Med Pharmacol Sci. 2021,25(5):2252-2259. doi: 10.26355/eurrev_202103_25257Read this paper
- Altay DU, Keha EE, Karagüzel E, et al. The Diagnostic Value of FNDC5/Irisin in Renal Cell Cancer. Int Braz J Urol. 2018,44(4):734-739. doi: 10.1590/S1677-5538.IBJU.2017.0404Read this paper
- Shi G, Tang N, Qiu J, et al. Irisin stimulates cell proliferation and invasion by targeting the PI3K/AKT pathway in human hepatocellular carcinoma. Biochem Biophys Res Commun. 2017,493(1):585-591. doi: 10.1016/j.bbrc.2017.08.148Read this paper
- Perakakis N, Triantafyllou GA, Fernández-Real JM, et al. Physiology and role of irisin in glucose homeostasis. Nat Rev Endocrinol. 2017,13(6):324-337. doi: 10.1038/nrendo.2016.221Read this paper
- Du XL, Jiang WX, Lv ZT. Lower Circulating Irisin Level in Patients with Diabetes Mellitus: A Systematic Review and Meta-Analysis. Horm Metab Res. 2016,48(10):644-652.Read this paper
- Kirbas A, Daglar K, Timur H, et al. Maternal circulating levels of irisin in intrahepatic cholestasis of pregnancy. J Matern Fetal Neonatal Med. 2016,29(21):3483-7. doi: 10.3109/14767058.2015.1132694Read this paper
- Zhang C, Ding Z, Lv G, et al. Lower irisin level in patients with type 2 diabetes mellitus: A case-control study and meta-analysis. J Diabetes. 2016,8(1):56-62. doi: 10.1111/1753-0407.12256Read this paper
- Rodríguez A, Becerril S, Méndez-Giménez L, et al. Leptin administration activates irisin-induced myogenesis via nitric oxide-dependent mechanisms, but reduces its effect on subcutaneous fat browning in mice. Int J Obes (Lond). 2015,39(3):397-407. doi: 10.1038/ijo.2014.166Read this paper
- Sanchis-Gomar F, Alis R, Pareja-Galeano H, et al. Inconsistency in circulating irisin levels: what is really happening? Horm Metab Res. 2014,46(8):591-6. doi: 10.1055/s-0033-1363283Read this paper
Related products
Product group Assays
- SizePrice
Product group Assays
Assay Sample TypeSerum, plasma, tissue homogenates and other biological fluids
- SizePrice
Product group Assays
Assay Sample TypeSerum, plasma and other biological fluids
- SizePrice